integrated DNA technologies
ActiveSummary
integrated DNA technologies has been active since 2000 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €15.4m and a net result of €7.7m. Equity remains stable across the filed financial years (±0.8% per year). Its solvency ranks better than 58% of 317 sector peers (NACE 20, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
Group and network
Holdings and subsidiaries
3 holdingsHoldings 3
Source for every holding own accounts 2025
- Integrated DNA Technologies Germany GmbHDEsubsidiaryEquity €10.3mResult €1.6m100%
- Integrated DNA Technologies Spain SLESsubsidiaryEquity €1.6mResult €331,528100%
- Integrated DNA Technologies UK LtdGBsubsidiaryEquity GBP 6.0mResult GBP 1.3m100%
According to the 2025 annual accounts of integrated DNA technologies and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
3 current directorsThe network starts from this company’s directors. Other companies they run appear here as nodes.